Home

Medical Services

Patient Guide

	Eye Center

	Patient Services

	FAQs

	Referring Physicians

	Physicians & Staff

	Patient Contact Info

	Appointments

	Emory Vision

	Make a Gift

	Clinical Trials

Comprehensive Care for Patients with Eye Cancers

Treating patients with cancer takes a very comprehensive medical approach. The Emory Eye Center has one of only a few ocular oncology sub-sections in the country that has ocular oncologists and ocular pathologists who, together with a number of researchers in other Emory departments, provide comprehensive care to patients with eye cancers.

The Ocular Oncology service at Emory includes expert medical and surgical care of patients with ocular (eye) and periocular (eyelid/orbit) malignant tumors. Following is some of the major research conducted by the service:

Retinal tumors. Emory's retina specialists have the latest surgical, laser and medical therapies for adult and pediatric patients with retinal tumors, including retinoblastoma, choroid melanoma and other types of eye malignancies.
Eyelid and orbital malignant tumors. The Eye Center's oculoplastic specialists provide medical and surgical care of patients with tumors of the eyelids, tear ducts or other structures surrounding the eye. The Eye Center's neuro-ophthalmologist provides care for structures damaged by disease (such as eyelid function) and one of Emory's dermatologists applies skin melanoma research to eyelid melanomas.
Pathology. The Eye Center's ocular pathologists serve as a liaison between basic science research and clinical care of patients with ocular and periocular malignant tumors. They have been developing and studying a genetically engineered mouse model of eye melanoma to determine the best course of treatment.
Drug delivery systems. Eye Center basic scientists and ophthalmologists are developing methods of introducing drugs directly into the eye to treat ocular tumors. Using a special gel, they have developed methods that can deliver drugs through the sclera that will be effective for as much as several weeks at a time. This technique may be used specifically for infants and children with retinoblastoma (a blinding tumor of the retina) to deliver anti-cancer drugs directly to the tumor rather than infusing it through the bloodstream.

ŤŤ back to Emory Eye Center Services